A licensed attorney with nearly a decade of experience in content production, Valerie Catalano knows how to help readers digest complicated information about the law in an approachable way. Her ...
Achieving the widely targeted USD 450 billion valuation for the Indian pharmaceutical industry by 2047 is impossible without the active coordination of all stakeholders, including associations, ...
The US Supreme Court ruled yesterday, June 4, that pharmaceutical company Hikma’s generic cardiovascular drug does not infringe global biopharmaceutical company Amarin’s patents covering its drug ...
With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic version of Amarin’s fish oil-derived cardiovascular drug Vascepa does not ...
WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...
The Supreme Court unanimously sided with generic drugmaker Hikma (HKMPF) and against Amarin Corp. (AMRN) in a case dealing with narrower labels for generic products compared to their brand equivalents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results